GPR120 has been positioned as one of the most attractive targets for relieving complications associated with obesity, and numerous pharmaceutically interesting drugs targeting this receptor have already been developed56. The gene discussed is FFAR4; the disease is obesity due to melanocortin 4 receptor deficiency.